NCT04750629View on ClinicalTrials.gov

Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)

CompletedOBSERVATIONAL

Enrollment

140

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

May 7, 2021

Study Completion Date

May 14, 2021

Conditions

SARS-CoV-2Covid19

Interventions

DEVICE

POC CoviDx™ Rapid Antigen Test

All patients will have a nasal swab for CoviDx™ Rapid Antigen testing

Trial Locations (2)

33016

Doral Medical Research, Hialeah

33409

Comprehensive Clinical Research, West Palm Beach

Sponsors

Lead Sponsor

Lumos Diagnostics

All Listed Sponsors

collaborator

Rapid Pathogen Screening

INDUSTRY

lead

Lumos Diagnostics

INDUSTRY

NCT04750629 - Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™) | Biotech Hunter | Biotech Hunter